Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 31 Issue 5
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2013  >  31(5): 355-356

LI Yang, WANG Hong-li. Efficacy of budesonide suspension for inhalation in the treatment of upper airway cough syndrome[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(5): 355-356. doi: 10.3969/j.issn.1006-0111.2013.05.009
Citation: LI Yang, WANG Hong-li. Efficacy of budesonide suspension for inhalation in the treatment of upper airway cough syndrome[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(5): 355-356. doi: 10.3969/j.issn.1006-0111.2013.05.009
shu

Efficacy of budesonide suspension for inhalation in the treatment of upper airway cough syndrome

doi: 10.3969/j.issn.1006-0111.2013.05.009

  • Department of E.N.T, Second Hospital of Ningbo Yinzhou, Ningbo 315100, China

  • Received Date: 2012-06-23
  • Rev Recd Date: 2012-11-28
  • Objective To observe clinical efficacy of budesonide suspension for inhalation (pulmicort respules) for treatment of upper airway cough syndrome. Methods The treatment group(31 patients) used 1mg budesonide suspension for inhalation partly by atomization inhalation via mask nose and mouth, which were used 2 times a day and course of two weeks. The control group (30 patients) were not used budesonide aerosol at all. At the same time, the two groups were added in oral loratadine 1 time a day and gino capsule 3 times a day and course of two weeks. Symptoms changes of twogroups used medication for 2 courses were observed before and after treatment. Results The overall effect of the patients treated with an effective rate of 96.8%, significantly better than the control group, which had a effective rate of 53.3%. (P<0.05). Conclusions Treatment of upper airway cough syndrome by aerosol inhalation budesonide suspension was effective, and the onset time and efficacy were higher than that in the control group.
  • [1] 中华医学会呼吸病学分会哮喘学组. 咳嗽的诊断与治疗指南(2009版)[J].中华结核和呼吸杂志,2009,32:407.
    [2] 中华医学会儿科学分会呼吸学组,中华儿科杂志编辑委员会.儿童慢性咳嗽诊断与治疗指南(试行)[J].中华儿科杂志,2008,46:104.
    [3] Pratter MR. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as posmasal drip syndrome): ACCP evidence-based clinical practice guidelines[J]. Chest, 2006, 129(1 Suppl):63S.
    [4] 喻清和,邱志南. 中西医结合治疗小儿鼻后滴漏致慢性咳嗽疗效观察[J]. 中医药学刊, 2006, 24 (12): 2353.
    [5] 谷庆隆,陆颖霞,庞 冲,等.儿童难治性咳嗽128例病因分析[J].中华耳鼻咽喉头颈外科杂志.2010,45(1):28.
    [6] 时翠芹,余 莉,魏为利,等.气道炎症在上气道咳嗽综合征发生中的作用[J].中国呼吸与危重监护杂志.2009,8(3):256.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2603) PDF downloads(69) Cited by()

Related
Proportional views

Efficacy of budesonide suspension for inhalation in the treatment of upper airway cough syndrome

doi: 10.3969/j.issn.1006-0111.2013.05.009
  • Department of E.N.T, Second Hospital of Ningbo Yinzhou, Ningbo 315100, China
  • Received Date: 2012-06-23
  • Rev Recd Date: 2012-11-28

Abstract: Objective To observe clinical efficacy of budesonide suspension for inhalation (pulmicort respules) for treatment of upper airway cough syndrome. Methods The treatment group(31 patients) used 1mg budesonide suspension for inhalation partly by atomization inhalation via mask nose and mouth, which were used 2 times a day and course of two weeks. The control group (30 patients) were not used budesonide aerosol at all. At the same time, the two groups were added in oral loratadine 1 time a day and gino capsule 3 times a day and course of two weeks. Symptoms changes of twogroups used medication for 2 courses were observed before and after treatment. Results The overall effect of the patients treated with an effective rate of 96.8%, significantly better than the control group, which had a effective rate of 53.3%. (P<0.05). Conclusions Treatment of upper airway cough syndrome by aerosol inhalation budesonide suspension was effective, and the onset time and efficacy were higher than that in the control group.

LI Yang, WANG Hong-li. Efficacy of budesonide suspension for inhalation in the treatment of upper airway cough syndrome[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(5): 355-356. doi: 10.3969/j.issn.1006-0111.2013.05.009
Citation: LI Yang, WANG Hong-li. Efficacy of budesonide suspension for inhalation in the treatment of upper airway cough syndrome[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(5): 355-356. doi: 10.3969/j.issn.1006-0111.2013.05.009
shu

    HTML

Reference (6)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return